Abstract
We aimed to assess differences in resting-state functional connectivity (FC) between distinct morphological MRI-phenotypes in multiple sclerosis (MS). Out of 180 MS patients, we identified those with high T2-hyperintense lesion load (T2-LL) and high normalized brain volume (NBV; a predominately white matter damage group, WMD; N = 37) and patients with low T2-LL and low NBV (N = 37; a predominately grey matter damage group; GMD). Independent component analysis of resting-state fMRI was used to test for differences in the sensorimotor network (SMN) between MS MRI-phenotypes and compared to 37 age-matched healthy controls (HC). The two MS groups did not differ regarding EDSS scores, disease duration and distribution of clinical phenotypes. WMD compared to GMD patients showed increased FC in all sub-units of the SMN (sex- and age-corrected). WMD patients had increased FC compared to HC and GMD patients in the central SMN (leg area). Only in the WMD group, higher EDSS scores and T2-LL correlated with decreased connectivity in SMN sub-units. MS patients with distinct morphological MRI-phenotypes also differ in brain function. The amount of focal white matter pathology but not global brain atrophy affects connectivity in the central SMN (leg area) of the SMN, consistent with the notion of a disconnection syndrome.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Multiple sclerosis (MS) is characterized by an inflammatory and neurodegenerative component and represents the major cause for non-traumatic disability in young adults1. While the complex pathogenesis of MS is incompletely understood, previous studies showed that inflammatory activity and neurodegeneration may to some degree be independent of each other2,3,4,5.
MRI is the best-studied tool to indirectly depict pathophysiologic mechanisms in MS in vivo2. Considering the heterogeneity of MRI findings even between patients with the same clinical phenotype, a categorization of patients based on morphological MRI characteristics has been proposed2,3,6,7,8.
While many patients display congruent extremes concerning the degree of focal inflammation and diffuse neurodegeneration, some MRI studies suggested that approximately 25–50% in fact may demonstrate a dissociation between inflammatory (predominantely white matter damage) and neurodegenerative (predominantely grey matter damage) pathology2,3,8.
Moreover, physical deficits in MS cannot fully be explained by cerebral structural damage, but also correlate with functional imbalances in and between brain networks9. Functional MRI (fMRI) studies have provided important insights into the role of functional reorganization related to structural damage in MS9,10,11. Studying functional connectivity (FC) using resting-state fMRI (rfMRI) is particularly attractive, as it remains uninfluenced by task performance12.
Previous studies showed increased physical disability in MS to be related to decreased FC in the default-mode network (DMN)13,14. In contrast, correlations between FC changes in the sensorimotor network (SMN) and physical disability were not consistently observed11,15,16,17,18. One possible explanation for these inconsistent correlations might be FC variations between MRI-phenotypes. We here aimed to assess potential differences in resting-state FC between MS patients with predominately white matter damage versus grey matter damage MRI-phenotypes.
Methods
Participants
This study is an analysis of a prospective study of patients with MS and healthy controls (HC) investigated between 2014 and 2017. The current study sample was selected according to the MRI morphologic criteria described below from a cohort of 180 MS patients19 from our outpatient MS clinic who had consecutively undergone brain MRI over a period of 26 months at the same 3 T scanner applying identical protocols including rfMRI data acquisition.
Patients had to have no relapse within the previous two months, had not received corticosteroids eight weeks prior to scanning, and had no history of serious psychiatric illness (e.g. depression) or other neurologic disorders than MS. Disability was assessed using the Expanded Disability Status Scale (EDSS) at the time of MRI scanning.
We also assessed 37 age-matched healthy controls (HC) free of neurological diseases, using the same protocol at the same scanner.
Standard protocol approvals, registrations, and patient consents
The study was approved by the ethics committee of the Medical University of Graz. The study was carried out in accordance with relevant guidelines and regulations. All participants gave written informed consent.
MRI data acquisition
MRI was performed on a 3 Tesla TimTrio scanner (Siemens Healthcare, Erlangen, Germany) using a 12-channel head coil. High-resolution structural 3D images were acquired by means of a T1-weighted MPRAGE sequence with 1 mm isotropic resolution (TI = 900 ms, TR = 1900 ms, TE = 2.19 ms, 176 slices). A T2-weighted fluid-attenuated inversion recovery (FLAIR) sequence with 1 × 1 × 3 mm³ resolution served for the assessment of the hyperintense T2-lesion load (T2-LL) in the patients (TI = 2500 ms, TR = 9000 ms; TE = 69 ms, 44 slices). rfMRI data were acquired with a single shot echo planar imaging sequence with 3 × 3 × 3 mm resolution (TR = 3000 ms; TE = 30; 150 volumes, field of view = 192 × 192 mm², Matrix = 64 × 64, 36 slices, slice thickness = 3 mm, acquisition time = 7.5 minutes). Participants were asked to close their eyes during rfMRI. The total imaging time was approximately 20 minutes.
Structural MRI analyses
Given our focus to investigate potential differences in SMN FC using a clinically applicable subtyping based on conventional MRI sequences, we chose to estimate the amount of grey matter damage on T1-weighted MPRAGE sequence and the amount of white matter damage on FLAIR images. The extent of grey matter damage was estimated by the normalized brain volume (NBV; in cm³) and the burden of focal white matter damage was estimated by the T2-lesion load (T2-LL)4.
After lesion filling with the FSL lesion filling toolbox, NBV was assessed from the T1-weighted MPRAGE images using SIENAX (Structural Image Evaluation, using Normalization, Single-Time-Point Estimation v 2.6), part of the FMRIB Software Library (FSL)20. T2-LL was assessed by a semi-automated region growing algorithm21 subsequent to lesion identification by a single experienced rater (CE).
We applied a median-split for NBV and T2-LL to identify distinct morphological phenotypes with a dissociation between white and grey matter pathology. Patients were separated into a group with predominately white matter damage phenotype without severe signs of neurodegeneration showing high T2-LL and high NBV (WMD) and into a predominately grey matter damage phenotype having low T2-LL and low NBV (GMD). An overview of the stratification procedure is shown in Fig. 1.
Analyses of rfMRI data
In the first step, individual resting state data were preprocessed using FEAT (FMRIB’s Expert Analysis Tool, v 6.0, part of FSL v 5.0.4). Individual pre-statistical processing included: motion correction using MCFLIRT, brain extraction, spatial smoothing using a Gaussian kernel of FWHM (full width at half maximum) of 6 mm22, high pass temporal filtering using a cut-off of 150 s (0.007 Hz), linear registration to the high resolution T1 scans (BBR) and non-linear registration using a warp resolution of 10 mm.
Next, Independent Component Analysis (ICA) was used for rfMRI data exploration (FSL-MELODIC, v 3.12), denoising the data and filtering out components based on high vs. low frequency content (fsl_regfilt command line tool). The resulting denoised functional images were resampled to standard space (MNI152 template 2 mm). To objectify identification of networks, we performed dual-regression analyses against ten resting-state templates from 36 healthy controls23 on the denoised, registered functional images of each subject in order to obtain objective individual spatial maps of the sensorimotor network (SMN).
Given the high prevalence and relevance of sensorimotor impairments in patients with MS, and importance of behavioural correlates (EDSS) for interpretation of rfMRI findings, we specifically focused on the SMN24. Hence, group functional connectivity maps of the SMN were computed for all groups and assessed for statistical significance (using “FSL Randomise”).
Regions of interest
Given the fact that functional reorganization mechanisms might differ between primary and supplementary motor areas, we further used five pre-defined functional sub-units of the SMN identified by Instantaneous Connectivity Parcellation (ICP) to assess possible differences and relationships of FC in a more refined approach25. These sub-units reflect biologically valid subdivisions of the SMN that adhere to known cytoarchitectural features25. We included ICP number 21 comprising the anterior SMN bilateral (shown in light blue, Fig. 2), ICP 22 (overlapping the supplementary motor area, shown in yellow Fig. 2), ICP 25 (overlapping the left hand area shown in green, Fig. 2), ICP 26 (overlapping the right hand area shown in red, Fig. 2) and a central SMN sub-unit, ICP 27 (overlapping the leg area, shown in dark blue, Fig. 2).
Sex- and age-corrected group differences of FC within the SMN and five sub-units of the SMN were assessed (using FSL Randomise, GLM with additional covariates).
Furthermore, sex- and age-corrected correlations between FC within each sub-network and morphological (NBV, T2-LL), as well as clinical (EDSS) measures, were computed for each group separately.
General statistical analysis
Clinical and morphological scores were analyzed with the Statistical Package of Social Science (IBM SPSS Statistics 23). The level of significance was set at 0.05. Comparisons concerning morphological (NBV, T2-LL) and clinical variables (EDSS, disease duration) between groups were done using unpaired t-tests or ANOVA for parametric and Mann Whitney U or Kruskal-Wallis tests for non-parametric dependent variables. Partial spearman correlations were performed correcting for age.
Results
Clinical and morphological features of patients with predominantely white and grey matter damage MRI-phenotypes compared to healthy controls
From the entire cohort of 180 patients, 74 patients with a distinct MRI phenotype were identified and considered for subsequent analyses based on the a priori defined MRI-stratification (see Fig. 1). This algorithm led to the identification of 37 patients with a predominately white matter damage MRI-phenotype (WMD) and 37 patients with a predominately grey matter damage MRI-phenotype (GMD).
Detailed characteristics of the entire patient cohort, the two subgroups with distinct MRI phenotypes and healthy controls (HC) are presented in Table 1.
Patients of the WMD-group were more often female and younger compared to GMD patients. The two groups did not differ significantly regarding EDSS, disease duration (DD) and distribution of clinical phenotypes. Higher EDSS scores correlated with higher T2-LL for all 180 patients (r = 0.21, p = 0.007, age-corrected) and within the WMD group (r = 0.357, p = 0.035, age corrected). Higher EDSS scores correlated with lower NBV (r = −0.266, p = 0.001, age corrected) for all 180 patients with MS, but not within the two subgroups.
The HC group did not differ compared to both groups with distinct MRI phenotypes regarding to age, but comprised less women. WMD patients and HC had comparable NBV and both had higher brain volumes compared to GMD patients.
Functional connectivity differences between patients with predominantely white vs. grey matter damage MRI-phenotypes compared to healthy controls
WMD patients showed higher FC in the SMN in the precentral gyri bilaterally and supplementary motor area (SMA) compared to GMD patients, even after correcting for differences in sex and age (Fig. 3). No significant whole brain differences were observed compared to HC, but region of interest analysis showed that WMD patients showed increased FC compared to HC and GMD patients in the central SMN (Fig. 3).
Higher FC in all five ICP sub-units of the SMN were observed for WMD patients compared to GMD patients in the precentral gyrus and SMA.
Correlations between functional connectivity, EDSS and morphological MRI metrics
All correlations between FC and EDSS or morphologic MRI metrics (T2-LL, NBV) were sex- and age-corrected.
Higher T2-LL was correlated with lower FC in the central SMN (leg area) in the WMD MRI-phenotype (Fig. 2; r = −0.357, p = 0.025 for extracted mean FC).
Higher EDSS scores (i.e. higher levels of physical disability) correlated with lower FC in four sub-units of the SMN (Fig. 2) in the WMD MRI-phenotype (correlation coefficients according to Fig. 2 for extracted mean FC left to right: r = −0.419, p = 0.012; r = −0.396, p = 0.019; r = −0.489, p = 0.003; r = −0.471, p = 0.004; see online Supplementary Fig. S1).
No correlations between T2-LL or EDSS scores and FC were observed for the GMD MRI-phenotype.
No correlations between NBV and FC were observed in any group.
Discussion
We found that patients with a predominately white matter damage MRI-phenotype showed increased FC in the sensorimotor network compared to those with a predominately grey matter damage MRI-phenotype. Decreased FC was further associated with higher EDSS scores and higher T2-LL, only in the WMD MRI-phenotype. Both groups did not differ regarding EDSS or disease duration and we controlled for potential confounding influences of sex and age.
Given the complexity and heterogeneity of MS in terms of clinical manifestations, clinical course and structural abnormalities26, a MRI-based stratification of patients has been proposed. The clinical-MRI paradox describes the poor correlation between conventional MRI measures and clinical disability27. Possible explanations for this include, on the one hand, the well-known limitations of conventional MRI (such as its inability to quantify MS related damage occurring within and outside T2-visible lesions) and, on the other hand, the shortcomings of the Expanded Disability Status Scale (EDSS), which, however, still represents the most frequently used tool to quantify the severity of neurological impairment and disability in patients with MS27. In addition, there is increasing evidence that the severity of the clinical manifestations of MS does not simply result from the extent of tissue destruction, but it rather represents a complex balance between tissue damage, tissue repair, and functional reorganization10. The application of functional MRI (fMRI)9,28,29 helped to improve our understanding of this complex interplay.
Several rfMRI studies have suggested altered FC patterns in patients with MS compared to healthy controls reporting that this technique is sensitive to brain functional reorganization30. Also differences in FC between clinical phenotypes have been reported, suggesting that an a priori stratification of patients with MS might be essential to assess potential functional differences16. However, to our knowledge this is the only study to investigate whether FC differs between distinct phenotypes defined by MRI. Therefore, we specifically focused on the two groups with a dissociation of a predominately WMD compared to the GMD phenotype defined by MRI. A stratification based on MRI measures provides an objective classification and reflects differential pathophysiologic mechanisms of MS. A new taxonomy on the basis of mechanisms rather than clinical empiricism could improve prediction of disease course and treatment2,31.
At group-level, increased SMN FC in the WMD group was observed, which could reflect a compensation mechanism given comparable EDSS scores between the groups. Region of interest analysis showed increased FC in the WMD group in the central SMN (leg area) also compared to healthy controls. However, within the WMD group, higher T2-LL and higher EDSS correlated with decreasing FC, suggesting that above a certain threshold of white matter damage, functional compensation of the network capacity breaks down32. Although our findings seem to support this network collapse theory, further confirmation in longitudinal studies is needed to explore functional reorganization in distinct MRI-phenotypes.
Furthermore, we found decreased FC in the central SMN (leg area) to be associated with increased focal white matter changes in WMD patients. This is in line with previous studies reporting an association between increased FC and decreased structural connectivity in the SMN in patients with MS33. Longitudinal studies have to determine whether such functional changes confer a systematic vulnerability to disease progression or, conversely, protect against the onset of deficits26,34.
Some limitations of our study have to be considered when interpreting our results. First, we only assessed cross-sectional differences of SMN FC in MRI-phenotypes and HC. Although previous studies showed that rfMRI networks are stable in MS,35 longitudinal assessments of rfMRI are essential to assess whether increases of FC are adaptive or maladaptive. Secondly, we are aware that more refined stratifications of patients based on MRI-phenotypes exist2. However, it was shown that unique subpopulations can be reliably identified using a simple distinction based on T2-lesion load and brain volume measures4. Furthermore, we aimed to use a potentially clinically applicable stratification based on conventional MRI sequences and therefore decided to use global T2-LL and NBV for identification of distinct groups. Thirdly, the EDSS range of our sample was rather narrow, including primarily patients with mild impairment. Further studies extending these findings within a sample with a broader spectrum of disease severity are warranted. Fourth, given the importance of behavioural correlates (e.g. EDSS) for interpretation of rfMRI findings we did not assess potential differences of other networks (e.g. cognitive networks or the default-mode network).
Also more refined quantitative MRI measures (such as e.g. magnetization transfer imaging36,37) might be useful to better understand the relationship between (micro)structural changes and functional reorganization in MRI-phenotypes. Furthermore, an additional consideration of e.g. the T1 black hole ratio might help to improve such stratification, however for this first approach we focused on T2-LL as a cumulative measure of the footprints of focal inflammation.
In summary, our findings suggest that mechanisms of functional reorganization differ between distinct phenotypes defined by MRI and therefore, such a stratification might be useful when A) assessing functional reorganization in large MS cohorts to get a clearer picture of the structure-function relationship in such MRI phenotypes or B) selecting patients for e.g. rehabilitative interventions as functional compensation mechanisms might differ between MRI phenotypes.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502–17 (2008).
Bielekova, B. et al. MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology 65, 1071–1076 (2005).
Tauhid, S., Neema, M., Healy, B. C., Weiner, H. L. & Bakshi, R. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis. J. Neurol. Sci. 346, 250–254 (2014).
Guttmann, C. R. G., Meier, D. S. & Holland, C. M. Can MRI reveal phenotypes of multiple sclerosis? Magn. Reson. Imaging 24, 475–481 (2006).
Louapre, C. & Lubetzki, C. Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes. Mult. Scler. 21, 1626–1628 (2015).
Vaneckova, M. et al. Patients’ stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis. Eur. Neurol. 61, 278–284 (2009).
Uher, T. et al. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach. Eur. J. Neurol. 1–10, https://doi.org/10.1111/ene.13200 (2016).
Hemond, C. C. et al. MRI phenotypes in MS: Longitudinal changes and miRNA signatures. Neurol. Neuroimmunol. NeuroInflammation 6, 1–12 (2019).
Schoonheim, M. M. & Filippi, M. Functional plasticity in MS: friend or foe? Neurology 79, 1418–9 (2012).
Rocca, M. A., De Meo, E. & Filippi, M. Functional MRI in investigating cognitive impairment in multiple sclerosis. Acta Neurol. Scand. 134, 39–46 (2016).
Enzinger, C. & Deluca, J. Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI. Neurology 1416–1417, https://doi.org/10.1212/WNL.0b013e31826d600d (2012).
Filippi, M. et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 11, 349–360 (2012).
Filippi, M., Agosta, F., Spinelli, E. & Rocca, M. Imaging resting state brain function in multiple sclerosis. J. Neurol. 260, 1709–13 (2013).
Sacco, R., Bonavita, S., Esposito, F., Tedeschi, G. & Gallo, A. The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. Mult. Scler. Int. 2013, 857807 (2013).
Faivre, A. et al. Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis. Mult. Scler. 18, 1251–1258 (2012).
Roosendaal, S. D. et al. Resting state networks change in clinically isolated syndrome. Brain 133, 1612–21 (2010).
Dogonowski, A.-M. et al. Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis. Mult. Scler. 19, 559–66 (2013).
Zhong, J. et al. Abnormal functional connectivity and cortical integrity influence dominant hand motor disability in multiple sclerosis: a multimodal analysis. Hum. Brain Mapp. 37, 4262–4275 (2016).
Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292–302 (2011).
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. Fsl. Neuroimage 62, 782–790 (2012).
Plummer, D. L. DispImage: a display and analysis tool for medical images. Rev Neuroradiol 5, 489–495 (1992).
Poldrack, R. A., Mumford, J. A. & Nichols, T. E. Handbook of functional MRI data analysis. (Cambridge University Press, 2011).
Smith, S. M. et al. Correspondence of the brain’ s functional architecture during activation and rest. PNAS 106, 13040–13045 (2009).
Peterson, D. S. & Fling, B. W. How changes in brain activity and connectivity are associated with motor performance in people with MS. NeuroImage Clin. 17, 153–162 (2018).
van Oort, E. S. B. et al. Functional parcellation using time courses of instantaneous connectivity. Neuroimage 1–10, https://doi.org/10.1016/j.neuroimage.2017.07.027 (2017).
Rocca, M. A. et al. Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis. Neurology 79, 1449–57 (2012).
Rovaris, M. & Filippi, M. ‘Importance sampling’: A strategy to overcome the clinical/MRI paradox in MS? J. Neurol. Sci. 237, 1–3 (2005).
Enzinger, C. et al. Longitudinal fMRI studies: Exploring brain plasticity and repair in MS. Mult. Scler. 22, 269–78 (2016).
Rocca, M. A. & Filippi, M. Functional MRI in multiple sclerosis. J. Neuroimaging 17(Suppl 1), 36S–41S (2007).
Faivre, A. et al. Brain functional plasticity at rest and during action in multiple sclerosis patients. J. Clin. Neurosci. 22, 1438–1443 (2015).
Roxburgh, R. H. S. R. et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64, 1144–51 (2005).
Schoonheim, M. M. & Meijer, K. A. & Geurts, J. J. G. Network Collapse and Cognitive Impairment in Multiple Sclerosis. Front. Neurol. 6, 1–5 (2015).
Lowe, M. J. et al. Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity. Hum. Brain Mapp. 29, 818–27 (2008).
Rocca, M. et al. Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment. Mult. Scler. J. 0–13, https://doi.org/10.1177/https (2017).
Pinter, D. et al. Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis. PLoS One 1–11, https://doi.org/10.1371/journal.pone.0152158 (2016).
Fazekas, F. et al. MTI of white matter hyperintensities. Brain 128, 2926–2932 (2005).
Ropele, S. & Fazekas, F. Magnetization Transfer MR Imaging in Multiple Sclerosis. Neuroimaging Clin. N. Am. 19, 27–36 (2009).
Author information
Authors and Affiliations
Contributions
D.P. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: D.P., F.F., C.E. Acquisition, analysis or interpretation of data: D.P., C.F.B., M.K., A.P., S.F., C.E. Drafting of the manuscript: D.P., C.E., F.F. Critical revision of the manuscript for important intellectual content: D.P., C.F.B., F.F., M.K., A.P., T.G., S.R., S.F., C.E. Statistical analysis: D.P. Administrative, technical or material support: S.R. Study supervision: C.E., F.F.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pinter, D., Beckmann, C.F., Fazekas, F. et al. Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function. Sci Rep 9, 16221 (2019). https://doi.org/10.1038/s41598-019-52757-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-52757-7
- Springer Nature Limited